Myriad Genetics | MYGN - Current Liabilities


Myriad Genetics reported $130.7M in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
Agilent USD 2.29B 20M Jun/2026
Becton, Dickinson and Co. USD 9.54B 139M Sep/2026
Bio-Rad Laboratories USD 969.1M 7.8M Sep/2026
Bruker USD 1.17B 32.6M Sep/2026
Danaher USD 9.05B 945M Sep/2026
Illumina USD 1.16B 422M Sep/2026
J&J USD 55.46B 562M Sep/2026
Mettler Toledo International USD 1.25B 49.81M Sep/2026
Myriad Genetics USD 130.7M 500K Jun/2026
OraSure Technologies USD 25.12M 18.96M Jun/2026
Pacific Biosciences Of California USD 66.59M 2.21M Sep/2026
Quest Diagnostics USD 1.83B 46M Sep/2026
Quidel USD 1.07B 73.7M Sep/2026
Repligen USD 125.69M 6.97M Sep/2026
Revvity USD 701.48M 574.88M Sep/2026
Standard Biotools USD 51.02M 5.78M Sep/2026
Thermo Fisher Scientific USD 14.17B 899M Sep/2026
Veracyte USD 84.21M 21.47M Sep/2026
Waters USD 2.4B 126M Jun/2026